Radiomics & Radiology: A Critical Step towards Integrated Healthcare
Radiomics & Radiology
Radiomics have shown great promise for integrated healthcare. Radiomics is defined as high-performance retrieval of significant volumes of characteristics from images and conversion of images to higher-dimensional data and subsequently mining for improved support for therapeutic judgements. It has its roots within Computer-Aided Detection (CAD)or Computer-Aided Diagnosis (CADx); it is unique in many aspects. It does not just detect and diagnose but also ventures into therapeutic, prediction, projection and modelling that can be used to generalize and reproduced. It has great potential in creating a paradigm shift in the way healthcare is delivered and perceived. We will review and outline the stage of radiomics& its SWOT analysis, exclusively addressing application in medical imaging and spotlighting the technical issues.
Gillies RJ, Kinahan PE, Hricak H. Radiomics: Images Are More than Pictures, They Are Data. Radiology. 2016;278(2):563–577. Available from: https://dx.doi.org/10.1148/radiol.2015151169.
Kotrotsou A, Zinn PO, Colen RR. Radiomics in Brain Tumors: An Emerging Technique for Characterization of Tumor Environment. Magn Reson Imaging Clin N Am . 2016;24(4):719–748. Available from: https://doi.org/10.1016/j.mric.2016.06.006.
Avanzo M, Stancanello J, Naqa IE. Beyond imaging: The promise of radiomics. Phys Med. 2017;38:122–161. Available from: https://doi.org/10.1016/j.ejmp.2017.05.071.
Kumar V, Gu Y, Basu S, Berglund A, Eschrich SA, Schabath MB, et al. Radiomics: the process and the challenges. Magn Reson Imaging. 2012;30(9):1234–1248. Available from: https://dx.doi.org/10.1016/j.mri.2012.06.010.
Wu J, Tha KK, Xing L, Li R. Radiomics and radiogenomics for precision radiotherapy. J Radiat Res. 2018;59(1):25–31. Available from: https://dx.doi.org/10.1093/jrr/rrx102.
Aerts H, Velazquez ER, Leijenaar R, Parmar C, Grossmann P, Cavalho S. Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun. 2014;5(4006). Available from: https://doi.org/10.1038/ncomms5006.
Grossmann P, Narayan V, Chang K, Rahman R, Abrey L, Reardon DA, et al. Quantitative imaging biomarkers for risk stratification of patients with recurrent glioblastoma treated with bevacizumab. Neuro-Oncology. 2017;19:1688–1697. Available from: https://dx.doi.org/10.1093/neuonc/nox092.
Wu J, Aguilera T, Shultz D, Gudur M, Rubin DL, Loo BW, et al. Early-Stage Non–Small Cell Lung Cancer: Quan- titative Imaging Characteristics of18F Fluorodeoxyglucose PET/CT Allow Prediction of Distant Metastasis. Radiology. 2016;281(1):270–278. Available from: https://dx.doi.org/10.1148/radiol.2016151829.
Cui Y, Song J, Pollom E, Alagappan M, Shirato H, Chang DT, et al. Quantitative Analysis of 18F-Fluorodeoxyglucose Positron Emission Tomography Identifies Novel Prognostic Imaging Biomarkers in Locally Advanced Pancreatic Cancer Patients Treated With Stereotactic Body Radiation Therapy. Int J Radiat Oncol Biol Phys. 2016;96(1):102–109. Available from: https://dx.doi.org/10.1016/j.ijrobp.2016.04.034.
van Rossum PSN, Fried DV, Zhang L, Hofstetter WL, van Vulpen M, Meijer GJ, et al. The Incremental Value of Subjective and Quantitative Assessment of 18F-FDG PET for the Prediction of Pathologic Complete Response to Preoperative Chemoradiotherapy in Esophageal Cancer. J Nuclear Med. 2016;57(5):691–700. Available from: https://dx.doi.org/10.2967/jnumed.115.163766.
Vallières M, Kay-Rivest E, Perrin LJ, Liem X, Furstoss C, Aerts H, et al. Radiomics strategies for risk assessment of tumour failure in head-and-neck cancer. . Sci Rep. 2017;7(1):10117. Available from: https://doi.org/10.1038/s41598-017-10371-5.
Fehr D, Veeraraghavan H, Wibmer A, Gondo T, Matsumoto K, Vargas HA, et al. Automatic classification of prostate cancer Gleason scores from multiparametric magnetic resonance images. Proc Natl Acad Sci. 2015;112(46):E6265–E6273. Available from: https://dx.doi.org/10.1073/pnas.1505935112.
Coroller TP, Grossmann P, Hou Y, Velazquez ER, Leijenaar RTH, Hermann G, et al. CT-based radiomic signature predicts distant metastasis in lung adenocarcinoma. Radiother Oncol. 2015;114(3):345–350. Available from: https://dx.doi.org/10.1016/j.radonc.2015.02.015.
Wibmer A, Hricak H, Gondo T, Matsumoto K, Veeraraghavan H, Fehr D, et al. Haralick texture analysis of prostate MRI: utility for differentiating non-cancerous prostate from prostate cancer and differentiating prostate cancers with different Gleason scores. Eur Radiol. 2015;25(10):2840–2850. Available from: https://dx.doi.org/10.1007/s00330-015-3701-8.
Gatenby RA, Grove O, Gillies RJ. Quantitative Imaging in Cancer Evolution and Ecology. Radiology. 2013;269(1):8–14. Available from: https://dx.doi.org/10.1148/radiol.13122697.
Gevaert O, Mitchell LA, Achrol AS, Xu J, Echegaray S, Steinberg GK, et al. Glioblastoma Multiforme: Exploratory Radiogenomic Analysis by Using Quantitative Image Features. Radiology. 2015;276(1):313–313. Available from: https://dx.doi.org/10.1148/radiol.2015154019.
Segal E, Sirlin CB, Ooi C, Adler AS, Gollub J, Chen X, et al. Decoding global gene expression programs in liver cancer by noninvasive imaging. Nat Biotechnol. 2007;25(6):675–680. Available from: https://dx.doi.org/10.1038/nbt1306.
Diehn M, Nardini C, Wang DS, McGovern S, Jayaraman M, Liang Y, et al. Identification of noninvasive imaging surrogates for brain tumor gene-expression modules. Proc Natl Acad Sci. 2008;105(13):5213–5218. Available from: https://dx.doi.org/10.1073/pnas.0801279105.
Kuo MD, Gollub J, Sirlin CB, Ooi C, Chen X. Radiogenomic Analysis to Identify Imaging Phenotypes Associated with Drug Response Gene Expression Programs in Hepatocellular Carcinoma. J Vasc Interv Radiol. 2007;18(7):821–830. Available from: https://dx.doi.org/10.1016/j.jvir.2007.04.031.
Vignati A, Mazzetti S, Giannini V, Russo F, Bollito E, Porpiglia F, et al. Texture features on T2-weighted magnetic resonance imaging: new potential biomarkers for prostate cancer aggressiveness. Phys Med Biol. 2015;60(7):2685– 2701. Available from: https://dx.doi.org/10.1088/0031-9155/60/7/2685.
Teruel JR, Heldahl MG, Goa PE, Pickles M, Lundgren S, Bathen TF, et al. Dynamic contrast-enhanced MRI texture analysis for pretreatment prediction of clinical and pathological response to neoadjuvant chemotherapy in patients with locally advanced breast cancer. NMR Biomed. 2014;27(8):887–896. Available from: https://dx.doi.org/10.1002/nbm.3132.
Klaeser B, Wiskirchen J, Wartenberg J, Weitzel T, Schmid RA, Mueller MD, et al. PET/CT-guided biopsies of metabolically active bone lesions: applications and clinical impact. Eur J Nucl Med Mol I. 2010;37(11):2027–2036. Available from: https://dx.doi.org/10.1007/s00259-010-1524-z.
Tatli S, Gerbaudo VH, Mamede M, Tuncali K, Shyn PB, Silverman SG. Abdominal Masses Sampled at PET/CT-guided Percutaneous Biopsy: Initial Experience with Registration of Prior PET/CT Images. Radiology. 2010;256(1):305–311. Available from: https://dx.doi.org/10.1148/radiol.10090931.
Buckler AJ, Bresolin L, Dunnick NR, and DCS. A Collaborative Enterprise for Multi-Stakeholder Participation in the Advancement of Quantitative Imaging. Radiology. 2011;258(3):906–914. Available from: https://dx.doi.org/10.1148/radiol.10100799.
Kalpathy-Cramer J, Freymann JB, Kirby JS, Kinahan PE, Prior FW. Quantitative Imaging Network: Data Sharing and Competitive AlgorithmValidation Leveraging The Cancer Imaging Archive. Transl Oncol. 2014;7(1):147–152. Available from: https://dx.doi.org/10.1593/tlo.13862.
Mackin D, Fave X, Zhang L, Fried D, Yang J, Tay- lor B, et al. Measuring Computed Tomography Scan- ner Variability of Radiomics Features. Invest Radiol. 2015;50(11):757–765. Available from: https://dx.doi.org/10.1097/rli.0000000000000180.
Zhao B, Tan Y, Tsai WY, Qi J, Xie C, Lu L, et al. Reproducibility of radiomics for deciphering tumor phenotype with imaging. Sci Rep. 2016;6:23428. Available from: https://doi.org/10.1038/srep23428.
Heilbrun ME. Evaluating RadLex and Real World Radiology Reporting. Acad Radiol. 2013;20:1327–1328. Available from: https://dx.doi.org/10.1016/j.acra.2013.09.011.
Copyright (c) 2020 Author
This work is licensed under a Creative Commons Attribution 4.0 International License.